A column-switching HPLC-MS/MS method for mucopolysaccharidosis type I analysis in a multiplex assay for the simultaneous newborn screening of six lysosomal storage disorders

2014 ◽  
Vol 28 (8) ◽  
pp. 1131-1139 ◽  
Author(s):  
Antonina Gucciardi ◽  
Elisa Legnini ◽  
Iole Maria Di Gangi ◽  
Carlo Corbetta ◽  
Rosella Tomanin ◽  
...  
2019 ◽  
Vol 5 (2) ◽  
pp. 24 ◽  
Author(s):  
Alberto B. Burlina ◽  
Giulia Polo ◽  
Laura Rubert ◽  
Daniela Gueraldi ◽  
Chiara Cazzorla ◽  
...  

The increasing availability of treatments and the importance of early intervention have stimulated interest in newborn screening for lysosomal storage diseases. Since 2015, 112,446 newborns in North Eastern Italy have been screened for four lysosomal disorders—mucopolysaccharidosis type I and Pompe, Fabry and Gaucher diseases—using a multiplexed tandem mass spectrometry (MS/MS) assay system. We recalled 138 neonates (0.12%) for collection of a second dried blood spot. Low activity was confirmed in 62 (0.06%), who underwent confirmatory testing. Twenty-five neonates (0.02%) were true positive: eight with Pompe disease; seven with Gaucher disease; eight with Fabry disease; and two with Mucopolysaccharidosis type I. The combined incidence of the four disorders was 1 in 4497 births. Except for Pompe disease, a second-tier test was implemented. We conclude that newborn screening for multiple lysosomal storage diseases combined with a second-tier test can largely eliminate false-positives and achieve rapid diagnosis.


2018 ◽  
Vol 4 (12) ◽  
pp. 1688-1696 ◽  
Author(s):  
Philipp Skrinjar ◽  
Markus Schwarz ◽  
Stefan Lexmüller ◽  
Thomas P. Mechtler ◽  
Maximilian Zeyda ◽  
...  

2019 ◽  
Vol 211 ◽  
pp. 193-200.e2 ◽  
Author(s):  
Jennifer L. Taylor ◽  
Kristin Clinard ◽  
Cynthia M. Powell ◽  
Catherine Rehder ◽  
Sarah P. Young ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document